A5020577078- Traumatic Brain Injury and Neurovascular Disturbances
- Cerebrospinal fluid and hydrocephalus
- Intracranial Aneurysms: Treatment and Complications
- S100 Proteins and Annexins
- Fetal and Pediatric Neurological Disorders
- Neurosurgical Procedures and Complications
- Vascular Malformations Diagnosis and Treatment
Umeå University
2018-2023
University Hospital of Umeå
2022
Introduction Endoscopic third ventriculostomy (ETV) is becoming an increasingly widespread treatment for hydrocephalus, but research primarily based on paediatric populations. In 2009, Kulkarni et al created the ETV Success score to predict outcome of in children. The purpose this study create a prognostic model success adult patients with hydrocephalus. ability who will benefit from allow better primary patient selection both and shunting. This would reduce additional second procedures due...
Abstract Background Early, objective prognostication after aneurysmal subarachnoid haemorrhage (aSAH) is difficult. A biochemical marker would be desirable. Correlation has been found between levels of the protein S100 beta (S100B) and outcome aSAH. Timing clinical usefulness are under investigation. Methods Eighty-nine patients admitted within 48 h aSAH were included. Modified ranking scale (mRS), EuroQoL health-related quality life measure (EQ-5D index ) visual analogue (EQ-VAS) values...
Abstract BACKGROUND Traumatic acute subdural hematomas (ASDHs) are associated with high rate of morbidity and mortality, especially in elderly individuals. However, recent reports indicate that the mortality rates might have improved. OBJECTIVE To evaluate postoperative (30-d) younger vs (≥70 yr) patients ASDH. Comparing patients, secondary objectives patterns care 6 mo outcome according to Glasgow scale (GOS). Finally, traumatic ASDH, we aim provide prognostic variables. METHODS This is a...
Early prognostication of long-term outcome in patients suffering from spontaneous subarachnoid hemorrhage (SAH) remains a challenge. No biomarkers are routinely used for prognostication. A previous study has indicated that the metabolite myo-inositol (MI) may be to predict outcome.To investigate if MI measured serum correlates with clinical SAH.We conducted an observational cohort including 88 treated SAH at Umeå University Hospital. Serum samples were collected hospital, and gas...
Prognostication of clinical outcome in patients suffering from aneurysmal subarachnoid haemorrhage (SAH) is a challenge. There are no biochemical markers routine use that can aid prognostication. Neurofilament light (NFL) measured cerebrospinal fluid (CSF) has been associated with previous studies.To investigate if serum levels NFL correlate CSF and long-term SAH.We conducted an observational cohort study 88 treated for SAH at Umeå University Hospital 2014-2018. Serum samples were analysed...